Breaking News Instant updates and real-time market news.

2021-11-11 09:10:45 NDAQ Nasdaq $207.29 / -3.47 (-1.65%) 09:10 11/11/21 11/11 09:10 11/11/21 09:10	Nasdaq launches Retail Trading Activity Tracker Nasdaq announced the launch of the Retail Trading Activity Tracker, a new dataset that provides reliable information into the trading activity of self-directed retail investors in the U.S. equity market. The Retail Trading Activity Tracker tracks stocks and exchange traded funds, ETFs, traded by individuals as well as buy/sell ratios per ticker on a daily basis. "The Retail Trading Activity Tracker brings enhanced transparency into the trading activity of retail investors and makes it available to all market participants," the company said. "The increased participation of individual investors is rapidly changing market dynamics, and the Retail Trading Activity Tracker is the first of its kind to offer general accessibility to consistent and standardized information on retail trading activity," said Oliver Albers, Senior Vice President and Head of Data, Investment Intelligence, Nasdaq. "The release of this new dataset underlines Nasdaq's mission of providing greater transparency and empowering the investing public with data-driven innovation. Through the expansion of Nasdaq Data Link and its library of datasets, we aim to level the playing field and make data, and by extension, the financial markets, more transparent and accessible to all."	30 Nov

2021-11-11 09:10:45

NDAQ

Nasdaq

$207.29 / -3.47 (-1.65%)

09:10

11/11/21

11/11

09:10

11/11/21

09:10

Nasdaq launches Retail Trading Activity Tracker

Nasdaq announced the launch of the Retail Trading Activity Tracker, a new dataset that provides reliable information into the trading activity of self-directed retail investors in the U.S. equity market. The Retail Trading Activity Tracker tracks stocks and exchange traded funds, ETFs, traded by individuals as well as buy/sell ratios per ticker on a daily basis. "The Retail Trading Activity Tracker brings enhanced transparency into the trading activity of retail investors and makes it available to all market participants," the company said. "The increased participation of individual investors is rapidly changing market dynamics, and the Retail Trading Activity Tracker is the first of its kind to offer general accessibility to consistent and standardized information on retail trading activity," said Oliver Albers, Senior Vice President and Head of Data, Investment Intelligence, Nasdaq. "The release of this new dataset underlines Nasdaq's mission of providing greater transparency and empowering the investing public with data-driven innovation. Through the expansion of Nasdaq Data Link and its library of datasets, we aim to level the playing field and make data, and by extension, the financial markets, more transparent and accessible to all."

30
Nov

OTHER BREAKING NEWS FROM THE FLY

Upgrade	8x8 upgraded to Buy from Neutral at BofA » 11:54 08/08/22 08/08 11:54 08/08/22 11:54 EGHT 8x8 $4.74 / +0.255 (+5.69%) BofA analyst Michael Funk… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EGHT 8x8 $4.74 / +0.255 (+5.69%) 07/18/22 8x8 names Suzy Seandel as Chief Accounting Officer EGHT 8x8 $4.74 / +0.255 (+5.69%) 11:53 Today BofA 8x8 upgraded to Buy from Neutral at BofA 08/05/22 Craig-Hallum 8x8 upgraded to Buy from Hold at Craig-Hallum 08/05/22 Oppenheimer 8x8 downgraded to Perform from Outperform at Oppenheimer 08/04/22 Oppenheimer 8x8 downgraded to Perform from Outperform at Oppenheimer EGHT 8x8 $4.74 / +0.255 (+5.69%) 07/27/22 8x8 sees FY23 revenue $720M-$730M, consensus $781.4M 07/27/22 8x8 sees Q2 revenue $177M-$180M, consensus $191.7M 07/27/22 8x8 reports Q1 EPS 9c, consensus 3c 05/10/22 8x8 sees FY23 revenue $740M-$755M, consensus $786.16M EGHT 8x8 $4.74 / +0.255 (+5.69%) 05/11/22 What You Missed On Wall Street On Wednesday 05/11/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: After-Hours Movers
Upgrade	8x8 upgraded to Buy from Neutral at BofA » 11:53 08/08/22 08/08 11:53 08/08/22 11:53 EGHT 8x8 $4.73 / +0.245 (+5.46%) BofA analyst Michael Funk… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EGHT 8x8 $4.73 / +0.245 (+5.46%) 07/18/22 8x8 names Suzy Seandel as Chief Accounting Officer EGHT 8x8 $4.73 / +0.245 (+5.46%) 08/05/22 Craig-Hallum 8x8 upgraded to Buy from Hold at Craig-Hallum 08/05/22 Oppenheimer 8x8 downgraded to Perform from Outperform at Oppenheimer 08/04/22 Oppenheimer 8x8 downgraded to Perform from Outperform at Oppenheimer 08/04/22 MKM Partners 8x8 initiated with a Neutral at MKM Partners EGHT 8x8 $4.73 / +0.245 (+5.46%) 07/27/22 8x8 sees FY23 revenue $720M-$730M, consensus $781.4M 07/27/22 8x8 sees Q2 revenue $177M-$180M, consensus $191.7M 07/27/22 8x8 reports Q1 EPS 9c, consensus 3c 05/10/22 8x8 sees FY23 revenue $740M-$755M, consensus $786.16M EGHT 8x8 $4.73 / +0.245 (+5.46%) 05/11/22 What You Missed On Wall Street On Wednesday 05/11/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: After-Hours Movers
Downgrade	Global Blood Therapeutics downgraded to Hold from Buy at Truist » 11:52 08/08/22 08/08 11:52 08/08/22 11:52 GBT Global Blood Therapeutics $66.73 / +2.92 (+4.58%) Truist analyst Joon Lee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events GBT Global Blood Therapeutics $66.73 / +2.92 (+4.58%) 06:49 Today Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 06:46 Today Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/05/22 Global Blood Therapeutics trading resumes 08/05/22 Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood GBT Global Blood Therapeutics $66.73 / +2.92 (+4.58%) 11:28 Today Stifel Global Blood Therapeutics downgraded to Hold from Buy at Stifel 10:02 Today William Blair Global Blood Therapeutics downgraded to Market Perform from Outperform at William Blair 09:28 Today Jefferies Global Blood Therapeutics downgraded to Hold from Buy at Jefferies 08:24 Today Piper Sandler Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler GBT Global Blood Therapeutics $66.73 / +2.92 (+4.58%) 05/04/22 Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30) 02/24/22 Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13) GBT Global Blood Therapeutics $66.73 / +2.92 (+4.58%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says GBT Global Blood Therapeutics $66.73 / +2.92 (+4.58%) 08:56 Today Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday 08/05/22 What You Missed On Wall Street This Morning 08/04/22 What You Missed On Wall Street On Thursday 16:30 Today Global Blood Therapeutics - GBT 08/30/22 Global Blood Therapeutics
General news	Treasury's $96 B 3- and 6-month bill auctions were well received » 11:50 08/08/22 08/08 11:50 08/08/22 11:50 $ECON Economic Data / + Treasury's $96 B 3-… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Recommendations	Uni-Select price target raised to C$44 from C$43 at TD Securities » 11:50 08/08/22 08/08 11:50 08/08/22 11:50 UNIEF Uni-Select $28.33 / -0.25 (-0.87%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research UNIEF Uni-Select $28.33 / -0.25 (-0.87%) 08/02/22 TD Securities Uni-Select price target raised to C$43 from C$36 at TD Securities 07/27/22 Desjardins Uni-Select price target raised to C$39 from C$37 at Desjardins 07/26/22 Canaccord Uni-Select price target raised to C$41 from C$39 at Canaccord 07/22/22 Canaccord Uni-Select price target raised to C$39 from C$35 at Canaccord
Hot Stocks	Lyft launches Lyft Media division » 11:49 08/08/22 08/08 11:49 08/08/22 11:49 LYFT Lyft $20.43 / +0.13 (+0.64%) In a blog post, Lyft… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LYFT Lyft $20.43 / +0.13 (+0.64%) 08/04/22 Lyft sees ride-share volumes exceeding pre-COVID levels 06/07/22 Lyft President, co-founder: We are seeing good signs of momentum 05/06/22 Lyft says Shared rides returning to more markets this May 05/03/22 Lyft drops 26% to $22.67 after Q2 revenue guidance misses estimates LYFT Lyft $20.43 / +0.13 (+0.64%) 09:16 Today Susquehanna Lyft price target lowered to $23 from $25 at Susquehanna 07:58 Today Deutsche Bank Lyft price target raised to $20 from $16 at Deutsche Bank 06:44 Today Wells Fargo Lyft price target lowered to $42 from $47 at Wells Fargo 08/05/22 Wedbush Lyft price target lowered to $25 from $32 at Wedbush LYFT Lyft $20.43 / +0.13 (+0.64%) 08/04/22 Lyft sees Q3 revenue $1.040B-$1.060B, consensus $1.12B 08/04/22 Lyft reports Q2 active riders 19.86M, up 15.9% 08/04/22 Lyft reports Q2 revenue $990.7M, consensus $990.46M 08/04/22 Notable companies reporting after market close LYFT Lyft $20.43 / +0.13 (+0.64%) 07/20/22 Lyft lays off about 60 people, or 2% of workforce, WSJ reports 06/17/22 Lyft to pay $25M to settle suit claiming it hid safety problems, Reuters reports 05/24/22 Lyft to slow hiring, slash budgets to reduce costs, WSJ reports 05/21/22 Some stocks that aren't as cheap as they look, Barron's says LYFT Lyft $20.43 / +0.13 (+0.64%) 08/04/22 Fly Intel: After-Hours Movers 07/13/22 What You Missed On Wall Street On Wednesday 07/13/22 What You Missed On Wall Street This Morning 07/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations LYFT Lyft $20.43 / +0.13 (+0.64%) 08/04/22 Lyft options imply 13.2% move in share price post-earnings 08/02/22 Unusually active option classes on open August 2nd 08/01/22 Lyft put volume heavy and directionally bearish 07/26/22 Lyft put volume heavy and directionally bearish
Recommendations	Ensign Energy price target lowered to C$6 from C$6.50 at TD Securities » 11:49 08/08/22 08/08 11:49 08/08/22 11:49 ESVIF Ensign Energy $2.30 / -0.04 (-1.71%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ESVIF Ensign Energy $2.30 / -0.04 (-1.71%) 05/10/22 RBC Capital Ensign Energy price target raised to C$6.50 from C$6 at RBC Capital 05/10/22 Stifel Ensign Energy price target raised to C$5.75 from C$5.50 at Stifel 05/10/22 TD Securities Ensign Energy price target raised to C$6.50 from C$6 at TD Securities 04/22/22 Canaccord Ensign Energy price target raised to C$4.50 from C$3 at Canaccord
Recommendations	Turquoise Hill price target lowered to C$38 from C$40 at TD Securities » 11:47 08/08/22 08/08 11:47 08/08/22 11:47 TRQ Turquoise Hill $24.90 / -0.24 (-0.95%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TRQ Turquoise Hill $24.90 / -0.24 (-0.95%) 06/14/22 Turquoise Hill announces first drawbell firing of Hugo North mine 05/18/22 Rio Tinto to amend funding plan with Turquoise Hill Resources 04/19/22 Turquoise Hill raises FY22 gold production view to 135K-165K ounces 04/19/22 Turquoise Hill reports Q1 gold production 59K ounces in concentrate, down 60% TRQ Turquoise Hill $24.90 / -0.24 (-0.95%) 07:42 Today Canaccord Turquoise Hill price target lowered to C$42 from C$44 at Canaccord 07/14/22 Canaccord Turquoise Hill price target lowered to C$44 from C$45 at Canaccord 07/07/22 Scotiabank Turquoise Hill price target lowered to C$42 from C$44 at Scotiabank 05/12/22 Scotiabank Turquoise Hill upgraded to Outperform from Sector Perform at Scotiabank TRQ Turquoise Hill $24.90 / -0.24 (-0.95%) 08/04/22 Turquoise Hill backs FY22 copper production guidance 08/04/22 Turquoise Hill reports Q2 EPS 51c, consensus 36c 05/10/22 Turquoise Hill reports Q1 EPS $1.37, consensus 28c TRQ Turquoise Hill $24.90 / -0.24 (-0.95%) 04/19/22 Fly Intel: After-Hours Movers 03/14/22 What You Missed On Wall Street On Monday 03/14/22 What You Missed On Wall Street This Morning
Recommendations	TransAlta price target lowered to C$18 from C$18.50 at TD Securities » 11:46 08/08/22 08/08 11:46 08/08/22 11:46 TAC TransAlta $10.60 / -0.075 (-0.70%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TAC TransAlta $10.60 / -0.075 (-0.70%) 06/10/22 Appeals Court upholds TransAlta's favorable force majeure arbitration decision 05/24/22 TSX approves TransAlta's notice to implement NCIB 04/05/22 TransAlta, Meta Platforms announce 200 MW renewable PPA TAC TransAlta $10.60 / -0.075 (-0.70%) 05/09/22 National Bank TransAlta price target raised to C$15 from C$14 at National Bank 03/22/22 BofA TransAlta downgraded to Neutral from Buy at BofA 01/12/22 TD Securities TransAlta price target lowered to C$17 from C$17.50 at TD Securities 01/11/22 CIBC TransAlta price target raised to C$17 from C$16.50 at CIBC TAC TransAlta $10.60 / -0.075 (-0.70%) 08/05/22 TransAlta reports Q2 EPS (30c), consensus 12c 05/06/22 TransAlta reports Q1 EPS 69c, consensus 6c 02/24/22 TransAlta reports Q4 EPS (29c), consensus 6c TAC TransAlta $10.60 / -0.075 (-0.70%) 04/06/22 #SocialStocks: Elon Musk gets involved with Twitter, shares and analysts respond
Recommendations	Telus price target raised to C$34 from C$33 at TD Securities » 11:46 08/08/22 08/08 11:46 08/08/22 11:46 TU Telus $22.85 / +0.49 (+2.19%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TU Telus $22.85 / +0.49 (+2.19%) 08/04/22 LifeWorks shareholders vote in favor of arrangement resolution with Telus 07/26/22 TELUS Agriculture expands to TELUS Agriculture & Consumer Goods 07/06/22 Telus provides 2M Canadians with access to digital person health record 07/05/22 Telus investing $23B across Ontario from 2022 to 2026 TU Telus $22.85 / +0.49 (+2.19%) 08:36 Today TD Securities Rogers Communications raised to Action List Buy at TD after recent weakness 06/28/22 Scotiabank Telus assumed with an Outperform at Scotiabank (yesterday) 06/17/22 BMO Capital Telus price target lowered to C$36 from C$37 at BMO Capital 06/17/22 TD Securities LifeWorks downgraded to Tender from Buy at TD Securities TU Telus $22.85 / +0.49 (+2.19%) 08/05/22 Telus reports Q2 EPS C$0.32 vs. C$0.26 a year ago 05/06/22 Telus backs FY22 operating revenue, adjusted EBITDA growth of 8%-10% 05/06/22 Telus reports Q1 adjusted basic EPS C$0.30 vs. C$0.27 a year ago 02/10/22 Telus reports Q4 adjusted basic EPS C$0.23c vs. C$0.22c a year ago

Recommendations	Heroux-Devtek price target lowered to C$21 from C$22 at TD Securities » 11:46 08/08/22 08/08 11:46 08/08/22 11:46 HERXF Heroux-Devtek $10.56 / -1.19 (-10.13%) TD Securities analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HERXF Heroux-Devtek $10.56 / -1.19 (-10.13%) 05/23/22 Desjardins Heroux-Devtek price target raised to C$27 from C$25 at Desjardins 05/20/22 Scotiabank Heroux-Devtek price target lowered to C$21 from C$24 at Scotiabank 05/20/22 National Bank Heroux-Devtek price target lowered to C$25 from C$26 at National Bank 02/11/22 Desjardins Heroux-Devtek price target lowered to C$25 from C$26 at Desjardins
General news	6-month bill auction » 11:46 08/08/22 08/08 11:46 08/08/22 11:46 $ECON Economic Data / + Total Amount: $42B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Recommendations	Dream Office REIT price target lowered to C$25 from C$26 at TD Securities » 11:45 08/08/22 08/08 11:45 08/08/22 11:45 DRETF Dream Office REIT $15.18 / -0.58 (-3.68%) TD Securities analyst Sam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DRETF Dream Office REIT $15.18 / -0.58 (-3.68%) 07/20/22 National Bank Dream Office REIT price target lowered to C$19 from C$27 at National Bank 05/10/22 Desjardins Dream Office REIT price target lowered to C$27 from C$28 at Desjardins 05/09/22 RBC Capital Dream Office REIT price target lowered to C$26 from C$27 at RBC Capital 05/09/22 Scotiabank Dream Office REIT price target lowered to C$26.25 from C$26.50 at Scotiabank
Recommendations	Canaccord Genuity price target lowered to C$12.50 from C$14 at TD Securities » 11:45 08/08/22 08/08 11:45 08/08/22 11:45 CCORF Canaccord Genuity $6.52 / -1.29 (-16.52%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CCORF Canaccord Genuity $6.52 / -1.29 (-16.52%) 06/29/22 Raymond James Canaccord Genuity initiated with an Outperform at Raymond James 06/06/22 TD Securities Canaccord Genuity price target lowered to C$14 from C$18 at TD Securities 04/11/22 TD Securities Canaccord Genuity price target lowered to C$18 from C$20 at TD Securities 12/20/21 TD Securities Canaccord Genuity price target raised to C$20 from C$19 at TD Securities
Options	Hertz Global Holdings call volume above normal and directionally bullish » 11:45 08/08/22 08/08 11:45 08/08/22 11:45 HTZ Hertz $22.01 / +0.39 (+1.80%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options HTZ Hertz $22.01 / +0.39 (+1.80%) 08/01/22 Hertz CEO: There is real opportunity under the brand to rebuild the company 06/28/22 Wheels Up, Hertz partner on new electric vehicle offerings 06/15/22 Hertz jumps 8% to $18.70 after announcing new $2B share repurchase plan 06/15/22 Hertz announces new $2B share repurchase program HTZ Hertz $22.01 / +0.39 (+1.80%) 07/29/22 Deutsche Bank Hertz price target raised to $38 from $29 at Deutsche Bank 07/14/22 Morgan Stanley Hertz price target lowered to $16 from $23 at Morgan Stanley 07/13/22 Deutsche Bank Hertz price target lowered to $29 from $36 at Deutsche Bank 07/05/22 Barclays Hertz price target lowered to $21 from $23 at Barclays HTZ Hertz $22.01 / +0.39 (+1.80%) 07/28/22 Hertz reports Q2 adjusted EPS $1.22, consensus $1.18 04/27/22 Hertz reports Q1 adjusted EPS 87c, consensus 83c 02/23/22 Hertz reports Q4 adjusted EPS 91c, consensus 76c 09 Nov HTZ Hertz $22.01 / +0.39 (+1.80%) 07/15/22 Hertz false-arrest claimaints file new lawsuit, Bloomberg reports 06/21/22 Hertz offers to settle roughly three dozen false arrest cases, Bloomberg says 03/24/22 Hertz adds Tesla's electric mid-size SUV to EV fleet, Reuters reports 02/24/22 Car rental companies expect shortages to continue, WSJ reports HTZ Hertz $22.01 / +0.39 (+1.80%) 07/28/22 What You Missed On Wall Street On Thursday 07/28/22 What You Missed On Wall Street This Morning 06/15/22 What You Missed On Wall Street On Wednesday 06/15/22 What You Missed On Wall Street This Morning HTZ Hertz $22.01 / +0.39 (+1.80%) 06/30/22 Hertz Global Holdings put volume heavy and directionally bearish 05/10/22 Hertz Global Holdings put volume heavy and directionally bearish 04/29/22 Hertz Global Holdings call volume above normal and directionally bullish 04/27/22 Hertz Global Holdings options imply 7.5% move in share price post-earnings
General news	3-month bill auction » 11:43 08/08/22 08/08 11:43 08/08/22 11:43 $ECON Economic Data / + Total Amount: $54B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Recommendations	AirBoss of America price target lowered to C$26 from C$31 at TD Securities » 11:43 08/08/22 08/08 11:43 08/08/22 11:43 ABSSF AirBoss of America $11.95 / +1.44959 (+13.81%) TD Securities analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ABSSF AirBoss of America $11.95 / +1.44959 (+13.81%) 08/03/22 Canaccord AirBoss of America price target lowered to C$20 from C$35.50 at Canaccord 07/29/22 TD Securities AirBoss of America price target lowered to C$31 from C$34 at TD Securities 06/22/22 Stifel AirBoss of America price target lowered to C$26.50 from C$45 at Stifel 06/17/22 TD Securities AirBoss of America price target lowered to C$34 from C$40 at TD Securities
Options	Futu Holdings put volume heavy and directionally bearish » 11:35 08/08/22 08/08 11:35 08/08/22 11:35 FUTU Futu Holdings $40.55 / -0.63 (-1.53%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options FUTU Futu Holdings $40.55 / -0.63 (-1.53%) 03/30/22 Futu Holdings added to SEC provisional list of companies under HFCAA 03/18/22 Jim Chanos announces new short position in Coinbase 03/18/22 Futu Holdings files annual report on Form 20-F FUTU Futu Holdings $40.55 / -0.63 (-1.53%) 06/23/22 JPMorgan Futu Holdings downgraded to Neutral after 47% rally at JPMorgan 06/23/22 JPMorgan Futu Holdings downgraded to Neutral from Overweight at JPMorgan 06/10/22 BofA BofA double upgrades Futu to Buy on upcoming positive developments 06/10/22 BofA Futu Holdings upgraded to Buy from Underperform at BofA FUTU Futu Holdings $40.55 / -0.63 (-1.53%) 06/24/22 What You Missed On Wall Street This Morning 06/03/22 Sell these stocks now, proven algorithm says 05/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations FUTU Futu Holdings $40.55 / -0.63 (-1.53%) 08/02/22 Futu Holdings put volume heavy and directionally bearish 07/15/22 Unusually active option classes on open July 15th 07/11/22 Unusually active option classes on open July 11th 07/06/22 Futu Holdings put volume heavy and directionally bearish
Downgrade	Global Blood Therapeutics downgraded to Hold from Buy at Stifel » 11:28 08/08/22 08/08 11:28 08/08/22 11:28 GBT Global Blood Therapeutics $66.72 / +2.91 (+4.56%) , PFE Pfizer $49.74 / +0.48 (+0.97%) , MRTX Mirati Therapeutics $89.95 / +3.5 (+4.05%) , CTIC CTI BioPharma $7.10 / -0.32 (-4.31%) , IOVA Iovance Biotherapeutics $12.76 / +0.59 (+4.85%) Stifel analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options GBT PFE MRTX CTIC IOVA GBT Global Blood Therapeutics $66.72 / +2.91 (+4.56%) 06:49 Today Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 06:46 Today Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/05/22 Global Blood Therapeutics trading resumes 08/05/22 Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood PFE Pfizer $49.74 / +0.48 (+0.97%) 06:49 Today Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 06:46 Today Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/07/22 Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE 08/05/22 Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood MRTX Mirati Therapeutics $89.95 / +3.5 (+4.05%) 06/06/22 Mirati Therapeutics announces results from Phase 1b cohort of KRYSTAL-1 05/27/22 Mirati Therapeutics trading resumes 05/27/22 Mirati Therapeutics trading halted, volatility trading pause 05/26/22 Mirati Therapeutics says disease control rate was 80% in study CTIC CTI BioPharma $7.10 / -0.32 (-4.31%) 06/10/22 CTI BioPharma presents data from pacritinib program at EHA 05/26/22 CTI BioPharma to present pivotal data on pacritinib program 04/14/22 CTI BioPharma's Vonjo included in NCCN Myeloproliferative Neoplasm guidelines 02/28/22 CTI BioPharma announces FDA accelerated approval of VONJO IOVA Iovance Biotherapeutics $12.76 / +0.59 (+4.85%) 06/02/22 Iovance Biotherapeutics director buys $6.6M in common stock 05/26/22 Iovance announces clinical data for lifileucel in advanced melanoma 04/05/22 Iovance Biotherapeutics provides regulatory update on lifileucel 03/15/22 Iovance Biotherapeutics announces FDA allows IOV-4001 IND to proceed GBT PFE MRTX CTIC IOVA GBT Global Blood Therapeutics $66.72 / +2.91 (+4.56%) 10:02 Today William Blair Global Blood Therapeutics downgraded to Market Perform from Outperform at William Blair 09:28 Today Jefferies Global Blood Therapeutics downgraded to Hold from Buy at Jefferies 08:24 Today Piper Sandler Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler 07:38 Today Canaccord Canaccord upgraded Global Blood to Buy before Pfizer takeover news PFE Pfizer $49.74 / +0.48 (+0.97%) 08:24 Today Piper Sandler Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler 08:19 Today Wedbush Wedbush downgrades Biohaven to Neutral, sees Pfizer acquisition on track 07:38 Today Canaccord Canaccord upgraded Global Blood to Buy before Pfizer takeover news 08/05/22 Truist Global Blood could complement any oncology franchise, says Truist MRTX Mirati Therapeutics $89.95 / +3.5 (+4.05%) 09:15 Today BofA Mirati Therapeutics price target raised to $88 from $79 at BofA 06:21 Today JMP Securities Mirati Therapeutics price target raised to $110 from $90 at JMP Securities 08/04/22 JMP Securities Mirati Therapeutics price target raised to $90 from $72 at JMP Securities 07/07/22 Citi Mirati Therapeutics price target lowered to $127 from $208 at Citi CTIC CTI BioPharma $7.10 / -0.32 (-4.31%) 07/07/22 Cowen Cowen starts CTI BioPharma at Outperform on 'high growth opportunity' 07/07/22 Cowen CTI BioPharma initiated with an Outperform at Cowen 04/14/22 Stifel Stifel reiterates Buy on CTI BioPharma following new treatment guidelines 03/01/22 Brookline CTI BioPharma price target raised to $12 from $7.20 at Brookline IOVA Iovance Biotherapeutics $12.76 / +0.59 (+4.85%) 08/05/22 Chardan Iovance Biotherapeutics price target lowered to $30 from $31 at Chardan 08/05/22 Baird Iovance Biotherapeutics price target lowered to $25 from $34 at Baird 05/27/22 H.C. Wainwright Iovance Biotherapeutics 'close to the finish line,' says H.C. Wainwright 05/27/22 Oppenheimer Iovance Biotherapeutics price target lowered to $27 from $31 at Oppenheimer GBT PFE MRTX CTIC IOVA GBT Global Blood Therapeutics $66.72 / +2.91 (+4.56%) 05/04/22 Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30) 02/24/22 Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13) PFE Pfizer $49.74 / +0.48 (+0.97%) 07/28/22 Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45 07/28/22 Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80 07/27/22 Notable companies reporting before tomorrow's open 07/27/22 Notable companies reporting before tomorrow's open MRTX Mirati Therapeutics $89.95 / +3.5 (+4.05%) 08/03/22 Mirati Therapeutics reports Q2 EPS ($3.18), consensus ($3.49) 02/28/22 Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00) 02/28/22 Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00) CTIC CTI BioPharma $7.10 / -0.32 (-4.31%) 05/12/22 CTI BioPharma reports Q1 EPS (23c), consensus (41c) 03/31/22 CTI BioPharma reports Q4 EPS (38c), consensus (28c) IOVA Iovance Biotherapeutics $12.76 / +0.59 (+4.85%) 08/04/22 Iovance Biotherapeutics reports Q2 EPS (63c), consensus (61c) 05/05/22 Iovance Biotherapeutics reports Q1 EPS (58c), consensus (64c) 11 Nov GBT PFE GBT Global Blood Therapeutics $66.72 / +2.91 (+4.56%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says PFE Pfizer $49.74 / +0.48 (+0.97%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says GBT PFE MRTX CTIC IOVA GBT Global Blood Therapeutics $66.72 / +2.91 (+4.56%) 08:56 Today Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday 08/05/22 What You Missed On Wall Street This Morning 08/04/22 What You Missed On Wall Street On Thursday PFE Pfizer $49.74 / +0.48 (+0.97%) 08:56 Today Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday 08/05/22 What You Missed On Wall Street This Morning 07/21/22 What You Missed On Wall Street On Thursday MRTX Mirati Therapeutics $89.95 / +3.5 (+4.05%) 06/07/22 What You Missed On Wall Street On Tuesday 06/07/22 What You Missed On Wall Street This Morning 06/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/27/22 What You Missed On Wall Street On Friday CTIC CTI BioPharma $7.10 / -0.32 (-4.31%) 06/27/22 Fly Insider: American Woodmark, Coursera among week's notable insider trades 05/13/22 What You Missed On Wall Street On Friday 05/13/22 What You Missed On Wall Street This Morning 04/01/22 What You Missed On Wall Street On Friday IOVA Iovance Biotherapeutics $12.76 / +0.59 (+4.85%) 05/27/22 What You Missed On Wall Street On Friday 05/27/22 What You Missed On Wall Street This Morning 05/26/22 Fly Intel: After-Hours Movers 04/05/22 Fly Intel: After-Hours Movers 00:00 Today Biotechnology Conference 08/15/22 2022 Biotech Summer Summit 09/10/22 ESMO Congress 2022 16:30 Today Global Blood Therapeutics - GBT 08/09/22 CTI BioPharma - CTIC 12/14/22 PDUFA Date for Adagrasib 08/30/22 Global Blood Therapeutics PFE CTIC IOVA PFE Pfizer $49.74 / +0.48 (+0.97%) 07/28/22 Unusually active option classes on open July 28th 06/30/22 Early notable gainers among liquid option names on June 30th 05/20/22 Early notable gainers among liquid option names on May 20th 04/26/22 Unusually active option classes on open April 26th CTIC CTI BioPharma $7.10 / -0.32 (-4.31%) 05/12/22 CTI BioPharma options imply 10.5% move in share price post-earnings 04/18/22 Unusually active option classes on open April 18th 03/31/22 CTI BioPharma options imply 5.3% move in share price post-earnings 03/24/22 CTI BioPharma options imply 7.9% move in share price post-earnings IOVA Iovance Biotherapeutics $12.76 / +0.59 (+4.85%) 06/27/22 Iovance Biotherapeutics call volume above normal and directionally bullish 06/03/22 Iovance Biotherapeutics call volume above normal and directionally bullish 05/05/22 Iovance Biotherapeutics options imply 9.8% move in share price post-earnings 04/29/22 Iovance Biotherapeutics call volume above normal and directionally bullish
Hot Stocks	Twilio reports hack of customer, employee accounts via text scheme » 11:26 08/08/22 08/08 11:26 08/08/22 11:26 TWLO Twilio $90.89 / +5.94 (+6.99%) In a Sunday incident… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TWLO Twilio $90.89 / +5.94 (+6.99%) 08/05/22 Twilio falls -15.2% 08/05/22 Twilio falls -17.4% 08/05/22 Twilio falls -15.6% 07/06/22 Cathie Wood's ARK Investment bought 120.5K shares of Twilio today TWLO Twilio $90.89 / +5.94 (+6.99%) 08/05/22 JMP Securities Twilio price target lowered to $175 from $250 at JMP Securities 08/05/22 Needham Twilio price target lowered to $140 from $200 at Needham 08/05/22 BTIG Twilio price target lowered to $130 from $230 at BTIG 08/05/22 Cowen Twilio price target lowered to $125 from $150 at Cowen TWLO Twilio $90.89 / +5.94 (+6.99%) 08/04/22 Twilio sees Q3 adjusted EPS (43c)-(37c), consensus (10c) 08/04/22 Twilio reports Q2 adjusted EPS (11c), consensus (20c) 08/04/22 Notable companies reporting after market close 05/04/22 Twilio sees Q2 EPS (23c) to (20c), consensus (13c) TWLO Twilio $90.89 / +5.94 (+6.99%) 08/05/22 What You Missed On Wall Street On Friday 08/05/22 What You Missed On Wall Street This Morning 08/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/04/22 Fly Intel: After-Hours Movers 08/23/22 Twilio - TWLO TWLO Twilio $90.89 / +5.94 (+6.99%) 08/04/22 Twilio options imply 10.6% move in share price post-earnings 05/04/22 Twilio options imply 15.1% move in share price post-earnings 04/18/22 Twilio call volume above normal and directionally bullish 02/11/22 Unusually active option classes on open February 11th

Options	Teladoc call volume above normal and directionally bullish » 11:25 08/08/22 08/08 11:25 08/08/22 11:25 TDOC Teladoc $39.68 / +2.22 (+5.93%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TDOC Teladoc $39.68 / +2.22 (+5.93%) 07/28/22 Cathie Wood's ARK Investment bought 408K shares of Teladoc today 07/25/22 Teladoc appoints Waters as COO 07/21/22 Teladoc down 9% after Amazon agrees to acquire One Medical 07/15/22 Teladoc releases new findings on integrated chronic care solutions TDOC Teladoc $39.68 / +2.22 (+5.93%) 08/02/22 Berenberg Berenberg downgrades Teladoc to Hold on 'underwhelming execution' 08/02/22 Cowen Teladoc downgraded to Market Perform from Outperform at Cowen 07/29/22 Deutsche Bank Teladoc price target lowered to $34 from $44 at Deutsche Bank 07/28/22 Stifel Teladoc price target lowered to $30 from $36 at Stifel TDOC Teladoc $39.68 / +2.22 (+5.93%) 07/27/22 Teladoc cuts FY22 EPS view to ($62.00)-($61.00) from ($43.50)-($43.00) 07/27/22 Teladoc sees Q3 EPS (85c)-(60c), consensus (55c) 07/27/22 Teladoc reports Q2 EPS ($19.22), consensus (64c) 07/27/22 Notable companies reporting after market close TDOC Teladoc $39.68 / +2.22 (+5.93%) 05/07/22 Disrupters getting punished, old-school rivals the winners, Barron's says 03/08/22 Lawmakers considering extending telehealth policies, STATNews reports TDOC Teladoc $39.68 / +2.22 (+5.93%) 08/05/22 Sell these stocks now, proven algorithm says 08/02/22 What You Missed On Wall Street On Tuesday 08/02/22 What You Missed On Wall Street This Morning 08/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations TDOC Teladoc $39.68 / +2.22 (+5.93%) 07/27/22 Teladoc options imply 16.7% move in share price post-earnings 07/26/22 Teladoc put volume heavy and directionally bearish 07/06/22 Unusually active option classes on open July 6th 06/30/22 Teladoc call volume above normal and directionally bullish
Technical Analysis	NASDAQ market internals summary » 11:17 08/08/22 08/08 11:17 08/08/22 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 08/05/22 NASDAQ market internals summary 08/05/22 NASDAQ market internals summary 08/05/22 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 08/08/22 08/08 11:16 08/08/22 11:16 $NYE NYSE Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 08/05/22 NYSE market internals summary 08/05/22 NYSE market internals summary 08/05/22 NYSE market internals summary
Downgrade	Bed Bath & Beyond downgraded to Hold from Buy at Odeon Capital » 11:14 08/08/22 08/08 11:14 08/08/22 11:14 BBBY Bed Bath & Beyond $11.69 / +3.54 (+43.44%) Odeon Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BBBY Bed Bath & Beyond $11.69 / +3.54 (+43.44%) 08/03/22 Bed Bath & Beyond down 3% to $5.62 after Bloomberg report on credit talks 07/21/22 Freeman Capital discloses 6.21% stake in Bed Bath & Beyond 07/07/22 Bed Bath & Beyond interim CEO Sue Gove buys 50,000 shares of common stock 07/04/22 Fly Intel: Top five weekend stock stories BBBY Bed Bath & Beyond $11.69 / +3.54 (+43.44%) 06/30/22 B. Riley Bed Bath & Beyond price target lowered to $5 from $7 at B. Riley 06/30/22 Baird Bed Bath & Beyond price target lowered to $4 from $7 at Baird 06/30/22 Loop Capital Bed Bath & Beyond price target lowered to $1 from $5 at Loop Capital 06/30/22 Morgan Stanley Bed Bath & Beyond price target lowered to $2 from $7 at Morgan Stanley BBBY Bed Bath & Beyond $11.69 / +3.54 (+43.44%) 06/29/22 Bed Bath & Beyond reports Q1 adjusted EPS ($2.83), consensus ($1.39) 06/28/22 Notable companies reporting before tomorrow's open 06/28/22 Notable companies reporting before tomorrow's open 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c BBBY Bed Bath & Beyond $11.69 / +3.54 (+43.44%) 08/03/22 Bed Bath & Beyond weighing private loans, Bloomberg reports 08/03/22 Bed Bath & Beyond in talks with private credit providers, Bloomberg says 07/02/22 Bed Bath & Beyond remodeling not working, Barron's says 06/29/22 Ryan Cohen happy with Bed Bath & Beyond CEO exit, CNBC reports BBBY Bed Bath & Beyond $11.69 / +3.54 (+43.44%) 08/07/22 Short Report: Bed Bath Beyond in short-squeeze spotlight 08/03/22 What You Missed On Wall Street On Wednesday 07/23/22 Short Report: Revlon shorts recede, stock retreats as buyout news fades 07/09/22 Short Report: Carvana, Bed Bath Beyond short interest continues to grow BBBY Bed Bath & Beyond $11.69 / +3.54 (+43.44%) 09:40 Today Unusually active option classes on open August 8th 08/05/22 Bed Bath & Beyond call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Bed Bath & Beyond call volume above normal and directionally bullish
Hot Stocks	American Power Group, Galileo Technologies US enter marketing collaboration » 11:08 08/08/22 08/08 11:08 08/08/22 11:08 APGI American Power Group / + American Power Group and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Earnings APGI American Power Group / + 08/02/22 American Power Group reports Q3 revenue $1.08M vs. $1.35M last year